International, Jan. 13, 2022 (GLOBE NEWSWIRE) — AscendEX is thrilled to announce the listing of the Battle of Guardians Share Token (BGS) under the trading pair BGS/USDT starting on January 14th at 2 p.m. UTC. Battle of Guardians (BOG) is
Entrants Can Submit Nominations in the Top Sales and Customer Service Awards Through February 2 Stevie Awards for Sales & -Service FAIRFAX, Va., Jan. 13, 2022 (GLOBE NEWSWIRE) — By popular demand, the Stevie® Awards have extended the final entry
NEW YORK, Jan. 13, 2022 (GLOBE NEWSWIRE) — Madison Realty Capital, a vertically integrated real estate private equity firm focused on debt and equity investment strategies, today announced that it has originated a $345 million loan to Cronin Development for
Recent Publications by Several Independent Laboratories Show ADG20 Has Neutralizing Activity with Potency Comparable to Other Antibodies that Retain Activity Against Omicron Multiple Efforts Underway to Address Omicron and Potential Future SARS-CoV-2 Variants WALTHAM, Mass., Jan. 12, 2022 (GLOBE NEWSWIRE)
NEW YORK, Jan. 11, 2022 (GLOBE NEWSWIRE) — Madison Realty Capital (“Madison”) today announced the final close of Madison Realty Capital Debt Fund V LP (“Fund V”), raising $2.08 billion in equity commitments, exceeding the fund’s $1.75 billion target. Fund
Rancho Santa Margarita, Calif., Jan. 11, 2022 (GLOBE NEWSWIRE) — Following food authority EFSA’s ban of food additive titanium dioxide (TiO2), Blue California, the producer of natural science-based ingredients, launched novel food-grade whitening agents as a clean-label alternative to replacing
Issued by the German Federal Office for Information Security, the Certification Reinforces Zoom’s Commitment to Security SAN JOSE, Calif., Jan. 10, 2022 (GLOBE NEWSWIRE) — Zoom Video Communications, Inc. (NASDAQ: ZM) today announced that Zoom Meeting Client version 5.6.6 has
MeMed raises $93M to accelerate commercialization of its host immune-response product portfolio MeMed BV® test recently cleared for use by US FDA to aid in distinguishing between bacterial and viral infection on the point-of-need platform MeMed Key® HAIFA, Israel; BOSTON,
Nyxoah Provides General Corporate Update Transformational 2021 positions Nyxoah for further clinical, regulatory, and commercial milestones in 2022 Mont-Saint-Guibert, Belgium – January 10, 2022, 7:00am CET / 1:00am ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH)(“Nyxoah” or the “Company”), a medical
BOSTON and SHANGHAI, China, Jan. 06, 2022 (GLOBE NEWSWIRE) — Zenas BioPharma, a global biopharmaceutical company committed to becoming a leader in the development and delivery of immune-based therapies, today announced the appointment of John Orloff, MD to its Board
Copyright © 2024 Oman Daily News. All Rights Reserved.